Clinical model for predicting rebleeding within 30 days after transcatheter arterial embolization for treating acute nonvariceal upper gastrointestinal bleeding

XIAO Weizhong,ZHANG Zhiyuan,SU Tianhao,YANG Siwei,LI Jian,ZHAO Yihao,JIN Long
DOI: https://doi.org/10.13929/j.issn.1672-8475.2023.05.009
2023-01-01
Abstract:Objective To establish a logistic model based on clinical data of acute nonvariceal upper gastrointestinal bleeding(ANVUGIB) patients, and to observe its value for predicting rebleeding within 30 days after transcatheter arterial embolization(TAE). Methods Totally 139 ANVUGIB patients who underwent TAE were enrolled. The technical success rate of TAE and the rebleeding rate within 30 days after TAE were observed. Based on clinical data, univariate and multiple analysis were performed to screen the impact factors of rebleeding. A clinical logistic model was then established, and its value for predicting rebleeding after TAE was analyzed. Results The technical success rate of TAE was 95.68%(133/139). During 30 days’ follow-up for 133 cases with successful TAE, rebleeding occurred in 29 cases(29/133,21.80%). Preoperative coagulation dysfunction(OR=3.74, P=0.045) and high Rockall score(OR=1.97, P=0.005) were risk factors for rebleeding within 30 days after TAE for ANVUGIB, while male(OR=0.19, P=0.007) and preoperative CT positive(OR=0.06, P=0.047) were protective factors. The sensitivity and specificity of logistic model based on the above 4 factors for predicting rebleeding within 30 days after TAE for ANVUGIB patients was 82.80% and 75.00%, respectively, and the area under the curve was 0.817, higher than that of Rockall score, Blackford score and Australian Institute of Medical Scientists 65 score(all P<0.05). Conclusion Clinical model based on gender, preoperative coagulation dysfunction, Rockall score and CT findings was helpful for predicting rebleeding within 30 days after TAE for ANVUGIB.
What problem does this paper attempt to address?